AzTrials
AzTrials

ObesityPhase 4NCT01556061

Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients

A Phase 4 study testing DMAC and CMAC in people with Obesity, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators hypothesize that the D-MAC (Dblade with C-MAC system) may be a suitable alternative device for difficult laryngoscopy and tracheal intubation in morbidly obese patients. The D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Obesity
What is being tested?
DMAC and CMAC
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
Jun 2011to Dec 2011
Phase
Phase 4
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18-65 years
  • ASA I-III
  • BMI ≥ 40 kg/m2

Who cannot join

  • Necessary awake intubation
  • Mallampati IV
  • < 2 finger breath or 4 cm mouth opening
  • Previous history of difficult intubation
  • ASA IV-V
  • Unstable cervical, thoracic and/or lumbar fracture
  • Known history of congestive heart failure or a severe disease that alters pulmonary mechanics (e.g. chronic obstructive pulmonary disease, restrictive lung diseases)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Memorial Hermann Hospital-TMC

    Houston, Texas, 77030

Other trials in United States

About this study

Official title: Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients - A Prospective Randomized Crossover Trial

The investigators hypothesize that the D-MAC (Dblade with C-MAC system) may be a suitable alternative device for difficult laryngoscopy and tracheal intubation in morbidly obese patients. The D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade. This is the first study to investigate the individual and comparative performances of C-MAC and D-MAC in this patient cohort.

Read the detailed description

Since the introduction of laryngoscopy, blades have undergone design innovations with the goal of improving laryngeal visualization and successful tracheal intubation because difficult intubation may be encountered even in patients with favorable anatomy.

Failed intubation shows occurrence in 0.05% of surgical patients and in 0.13% to 0.35% of obstetric and obese patients and the incidence of unsuspected difficult intubation is estimated to be higher at approximately 3%, with poor airway visualization being a major contributing factor.

Moreover airway management in the obese patient population requires special consideration. An increased BMI is associated with reduced posterior airway space and improper mask ventilation, both of which may lead to rapid development of hypoxemia and possible desaturation immediately after anesthetic induction.

As the prevalence of obesity has increased from 23% in 1992 to 33.8% in 2008 and an estimated 140,000 surgical bariatric cases are performed in the U.S., anesthesiologists face challenges of airway management in this population.

The main advantage of video intubation is provision of superior views compared to traditional laryngoscopy.

This study is designed to determine preliminarily the efficacy of the the D-BLADE [D-MAC] intubation systems compared to C-MAC in the bariatric population. The hypothesis is that D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade.

  1. General Study Design- The study will include a total of 50 morbidly obese patients (BMI ≥ 40kg/m2) scheduled for elective surgery (bariatric, gynecological, urological, general abdominal and otorhinolaryngology) at Memorial Hermann Hospital.

All patients will be intubated using conventional endotracheal tubes and preferably without any alternative aid to intubation. Patient will be followed for the time they will spend in the operating block (from the airway assessment time to the time of PACU discharge).

In the operating room, ASA standard monitoring devices will be applied: a pulse oximeter, a 3 lead ECG, and a blood pressure cuff (or invasive blood pressure depending on the patients' conditions). Pre-induction baseline measurements of blood pressure, heart rate, percent oxygen saturation and end tidal CO2 will be made. Patients will be positioned in a head elevated position (RAMP or TROOP pillow) and pre-oxygenated for 5 minutes. One set of pre-insertion vital signs (after induction) will be obtained. From the time anesthetic induction is begun until five minutes after the patient has been successfully intubated, five sets of vital signs will be recorded at one minute intervals. General anesthesia will be induced by bolus administration of propofol (2-3 mg/kg), fentanyl (2 mcg/kg), and succinylcholine (1mg/kg) per ideal body weight (assuming an ideal BMI of 32 kg/m2 up to a BMI of 50 kg/m2 and an ideal BMI 35 kg/m2 over 50 kg/m2. A rapid sequence induction (RSI) will be performed. RSI will be achieved with suxamethonium.The lungs will be mechanically ventilated with a semi-closed circle system to maintain an end-tidal CO2 near 35 mmHg. Patients' lungs will be ventilated via face-mask for 3 minutes with 100% oxygen until the patient is completely relaxed.

A ll investigators (residents and attending) will be trained based on manufacturer recommendations, and each resident will perform at least 3 intubations with the C-MAC and D-MAC video laryngoscope prior to enlisting any patients for the study. Intubations will be performed by 2nd and 3rd year (CA-2 and CA-3) residents. Size 3 blades of CMAC will be utilized in all cases (a size 4 will be available if necessary).

A computer-generated list will randomize the order of C-MAC and D-MAC to prevent bias. The resident will use either the C-MAC first followed by the D-MAC, or viceversa, and will declare the Cormack-Lehane Scale score for each method. Intubation will be attempted after the second laryngoscopy technique being used. External neck pressure may be applied by an assistant to improve laryngeal exposure. Any external manipulation will be recorded, and the optimal view obtained and the time required to obtain it for each method will be recorded.

The resident will have only one attempt each for C-MAC and D-MAC laryngoscopy. If the first attempt is unsuccessful, the attending anesthesiologist will take one more attempt for that particular method, C-MAC or D-MAC. The number of attempts (maximum 4 total as defined by reinsertion of either the blade or endotracheal tube), time required to obtain optimum view, CL score of view, and time required to intubate will all be recorded. Intubation time is defined by time from which the anesthesiologist has ETT in hand to when the ETT cuff passes distally through vocal cords. If unsuccessful, the direct laryngoscopy/flexible fiberoptic laryngoscopy will be performed to intubate the trachea. If more than 4 attempts are needed, or if the anesthesiologist discontinues use of the video laryngoscope, the case will be considered a failure. The resident's subjective opinion on laryngoscopy and intubation difficulty level (from 1 = Extremely Easy, to 5 = Extremely Difficult) will also be recorded.

In order to maintain patient safety all intubation attempts will be performed within the safety apnea time or time for oxygen blood saturation to drop to 92%.

  1. Measurements Pre-operatively, morphometric characteristics of all patients will be recorded: Mallampati score, adequacy of neck mobility, neck circumference, thyromental distance, sternomental distance, and interincisor gap distance.

Degree of irritation: Following intubation in either group, the appearance of oropharynx, pharynx, epiglottis, and arytenoids will be checked. The presence of abrasions, bleeding, redness, perforation or other signs of tissue or dental injury will be recorded. Also, the patient's subjective report of soreness, hoarseness, or dysphagia post-operatively will be recorded as well.

DATA ANALYSIS:

This investigation will serve as preliminary study to determine if there is an improved rate of airway view during C-MAC or D-MAC video laryngoscopy. The study will have a time frame of 12 months. Data will be summarized using mean ± SD, median and interquantile, and frequency (%) for discrete variables by each group. Appropriate tests like t-test, ANOVA, chi-squared, and Fischer tests will be used to compare the mean primary outcome variable, duration of desaturation, between two groups after adjusting the effects of risk factors.

For the secondary outcome variables, appropriate tests like t-test, ANOVA, or the chi-squared tests will be performed to compare the continuous variables between two groups to compare the percentage of discrete outcome variables between two groups.

Statistical analyses will be conducted using STATA 10.0 College Station, TX and a p-value < 0.05 will be considered as statistical significant.

Conditions
Obesity
Being tested
DMAC, CMAC
Keywords
Laryngoscopy, Airway Management, Intubation
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DMACDevice

    Also called D-Blade CMAC system

    The D blade will constitute the experimental treatment and in a cross over fashion will be tested against CMAC blade

  • CMACDevice

    Also called CMAC blade

    The CMAC Blade will constitute the active comparator treatment and in a cross over fashion will be tested against D-blade

Study groups in NCT01556061
Study groupRoleWhat they receive
D-MAC video laryngoscopyExperimentalThe Dblade is used to perfom laryngoscopy first but second laryngoscopy and intubation is performed with CMAC blade.
Receives: Device: DMAC; Device: CMAC
C-MAC video laryngoscopyActive comparatorThe CMAC blade is used to perfom laryngoscopy first but second laryngoscopy and intubation is performed with D-blade
Receives: Device: DMAC; Device: CMAC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time for Intubation

    Time taken for successful placement of endotracheal tube after a successful laryngoscopy. Typically a successful laryngoscopy will range from few seconds to no more than 90 seconds. A successful intubation will not range more than 90 seconds.

    Measured: 90 seconds

Secondary outcomes (2)
  1. First Laryngoscopy

    Patients underwent laryngoscopy first with their assigned randomized laryngoscope. Time measured was from the time from the moment the anesthesiologist had the laryngoscope in hand to time to optimal visualization of vocal cords.

    Measured: 30 seconds

  2. Second Laryngoscopy

    A second laryngoscopy will be performed in patients with the video laryngoscope from the other group. Patients will be intubated after second laryngoscopy with with this same video laryngoscope.

    Measured: 30 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2012 (estimated)
  2. Study startJun 2011
  3. Primary completionDec 2011
  4. Study completionDec 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01556061
Sponsor's protocol ID
HSC-MS-10-0573
Status last verified
Apr 2014
First submitted
1 Mar 2012
Last updated
26 May 2014
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing DMAC and CMAC in people with Obesity, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 May 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 May 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time for Intubation (time frame: 90 seconds). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in